Ying Wang
26Patents
5h-index
67Co-inventors
72Inventor score
Filing activity: Mar 26, 1998 → Aug 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7629330B2 | Use of zwitterionic polysaccharides for the specific modulation of immune processes | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5989542A | Capsular polysaccharides from enterococci | Human Necessities | 26 | Expired |
| US7083777B1 | Immunomodulating polymers | Human Necessities | 14 | Expired |
| US6274144A | Method for generating antibodies to saccharide fragments | Chemistry; Metallurgy | 10 | Expired |
| US6027733A | Method for generating saccharide fragments | Chemistry; Metallurgy | 10 | Expired |
| US11571391B2 | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant | Performing Operations; Transporting | 3 | Active |
| US10987430B2 | Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof | Chemistry; Metallurgy | 2 | Active |
| US6722062B2 | Capsular polysaccharides from enterococci | Chemistry; Metallurgy | 2 | Expired |
| US10564514B1 | Nonlinear optical crystal of cesium fluorooxoborate, and method of preparation and use thereof | Physics | 2 | Active |
| US11161891B2 | Relaxin immunoglobulin fusion proteins and methods of use | Chemistry; Metallurgy | 1 | Active |
| US8592223B2 | Use of periostin as a novel biomarker | Physics | 1 | Active |
| US12275771B2 | Relaxin immunoglobulin fusion proteins and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11541108B2 | Targeted gene disruption methods and immunogenic compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11180763B2 | CRISPR/Cas9 vector combination and application thereof in gene knockout | Chemistry; Metallurgy | 0 | Active |
| US11266674B2 | Pharmaceutical composition for tumor treatment or prevention, method, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8460884B2 | Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease | Physics | 0 | Active |
| US11761010B2 | Soybean genetic transformation method using PMI as selectable gene | Chemistry; Metallurgy | 0 | Active |
| US10117390B2 | Use of genic male sterility gene and mutation thereof in hybridization | Chemistry; Metallurgy | 0 | Active |
| US9198900B2 | Treatment of peritoneal injury using JAK inhibitors | Physics | 0 | Active |
| US7465453B2 | Polypeptide fragments of CKLF1 | Chemistry; Metallurgy | 0 | Active |
| US8916567B2 | Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof | Human Necessities | 0 | Active |
| US12168049B2 | Attenuated flaviviruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US10856481B2 | Use of genic male sterility gene and mutation thereof in hybridization | Chemistry; Metallurgy | 0 | Active |
| US8911723B2 | Hybrid hydrogel scaffold compositions and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12178869B2 | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.